Co-Diagnostics, Inc.
CODX
$0.2951
-$0.005-1.67%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 50.30K | 149.30K | 206.90K | 161.10K | 252.70K |
| Total Other Revenue | -- | 0.00 | 434.30K | 2.50M | 215.10K |
| Total Revenue | 50.30K | 149.30K | 641.10K | 2.66M | 467.90K |
| Cost of Revenue | 21.60K | 255.10K | 297.40K | 212.10K | 234.50K |
| Gross Profit | 28.70K | -105.70K | 343.70K | 2.44M | 233.30K |
| SG&A Expenses | 3.43M | 6.64M | 5.35M | 4.17M | 4.48M |
| Depreciation & Amortization | 280.40K | 357.10K | 351.20K | 338.30K | 330.60K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 8.60M | 12.06M | 10.88M | 10.34M | 10.73M |
| Operating Income | -8.55M | -11.91M | -10.23M | -7.68M | -10.26M |
| Income Before Tax | -7.52M | -11.04M | -9.67M | -7.58M | -9.29M |
| Income Tax Expenses | 12.00K | -8.20K | 22.20K | 20.60K | 22.80K |
| Earnings from Continuing Operations | -7.53M | -11.03M | -9.70M | -7.60M | -9.31M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -7.53M | -11.03M | -9.70M | -7.60M | -9.31M |
| EBIT | -8.55M | -11.91M | -10.23M | -7.68M | -10.26M |
| EBITDA | -8.27M | -11.55M | -9.88M | -7.34M | -9.93M |
| EPS Basic | -0.24 | -0.36 | -0.32 | -0.25 | -0.31 |
| Normalized Basic EPS | -0.17 | -0.24 | -0.20 | -0.15 | -0.21 |
| EPS Diluted | -0.24 | -0.36 | -0.32 | -0.25 | -0.31 |
| Normalized Diluted EPS | -0.17 | -0.24 | -0.20 | -0.15 | -0.21 |
| Average Basic Shares Outstanding | 32.05M | 30.88M | 30.49M | 30.12M | 29.84M |
| Average Diluted Shares Outstanding | 32.05M | 30.88M | 30.49M | 30.12M | 29.84M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |